Bridging the Gap: Patient Experience 2.0 — Redesigning Healthcare for Real People
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
24 results for “thc”
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
People who consumed THC were more likely to recall words that were never shown to them.
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
Cannabis Health has partnered with experts at the Medical Cannabis Clinicians Society to host its first event for healthcare professionals.
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year.
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot […]
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia.
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
The number of exposures to Delta 8-THC increased by 79% from 2021 to 2022, with reports ‘significantly lower’ in states with access to legal cannabis.
Long-term treatment with THC has been found to have cognition enhancing and anti-ageing effects, according to new research. Researchers from the University Hospital Bonn (UKB) and the University of Bonn […]
A daily dose of more than 4.7mg ‘significantly prolonged’ survival time and also improved quality of life.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
The study is the first to explore how genetic differences affect individual responses to THC.
Researchers found no association between more potent cannabis and an increased risk of dependence or psychosis-like symptoms.
As new findings emerge, what do we know about cannabis and diabetes so far?
The findings help us understand the therapeutic effects of THC at the molecular level.
New research says CBD may not reduce the negative effects of THC, despite previous studies suggesting otherwise.
Researchers say THC potency is not necessarily indicative of better quality, or a more positive experience.
A new clinical shows CBD can help offset some of the unwanted effects of THC.
Researchers in the US have been investigating whether the effects are the same.
UK patients reported improvements in overall quality of life, pain severity and symptoms of anxiety.